Based in Boston, Genosco is a clinical stage biotech specializing in
the discovery and development of novel kinase inhibitors for
patients with unmet medical needs
Based in Boston, Genosco is a clinical stage
biotech specializing in the discovery and development
of novel kinase inhibitors for patients with unmet
medical needs
-
01.Experienced
TeamDedicated team of experts in
kinase targeted therapies -
02.Proprietary
Discovery
PlatformG-SMART™ platform enables us
to identify rare sequences and
rapidly generate highly
selective compounds -
03.Strong and
Diverse
PipelineMultiple independent and
partnered pipelines -
04.Proven Track
RecordBacked by successful
out-licensing partnership
-
01.Experienced
TeamDedicated team of experts in
kinase targeted therapies -
02.Proprietary
Discovery
PlatformG-SMART™ platform enables us
to identify rare sequences and
rapidly generate highly
selective compounds -
03.Strong and
Diverse
PipelineMultiple independent and
partnered pipelines -
04.Proven Track
RecordBacked by successful
out-licensing partnership
Mapping / profiling of ATP
binding sites of 470+ human kinases
Proprietary chemical
library of 3,500+ master scaffolds
to rapidly discover, test and
optimize selective compounds
- Immune Thrombocytopenia (ITP)
- Systemic Lupus Erythematosus (SLE)
- Sjogren’s Syndrome
- Psoriasis
- ANCA-associated Vasculitis (AAV)
- Idiopathic Pulmonary Fibrosis (IPF)
- Cancer / Immuno-oncology
- Nonalcoholic Steatohepatitis (NASH)
- Central Nervous System (CNS)
To achieve this, it is important to focus on strengthening the discovery platform based on cutting-edge science,
and to create an open and positive working environment where employees can unleash their full creativity.